<DOC>
	<DOCNO>NCT01531322</DOCNO>
	<brief_summary>This study ass safety tolerability single dose 13-valent Pneumococcal Conjugate Vaccine approximately 1 month vaccination sequentially healthy Chinese adult age 18 55 year , follow child age 3 5 year , infant age approximately 2 month .</brief_summary>
	<brief_title>A Study Assessing 13-valent Pneumococcal Conjugate Vaccine Healthy Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1 . Age time enrollment : 18 55 year ( fifty sixth birthday ) Group 1 . 3 5 year ( sixth birthday ) Group 2 . 42 98 day Group 3 . 2 . Healthy subject determine medical history , physical examination , judgment investigator . Previous vaccination license investigational pneumococcal vaccine . Previous anaphylactic reaction vaccine vaccinerelated component . Contraindication vaccination pneumococcal vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>13vPnC</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>China</keyword>
</DOC>